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Abstract: Purpose:  This study aimed to evaluate the ocular alterations especially on retinal
microvasculature of obese patients and to determine the association of these
alterations with clinical features.
Material and Methods:  Height, body weight, blood lipid and glucose levels were
recorded in all patients. BMI was calculated.In all participants, biochemical
examinations were performed including cholesterol levels, fasting blood glucose,
fasting insulin,CRP,Hb A1C levels.The atherogenic index of plasma was calculated as
a logarithm of the ratio of the molar concentration (mmol/l) of TG to HDL-C (log
[TG/HDL-C]).Patients with a BMI ≤ 25 kg/m  2  were included in the control group.
Obese patients were sub-grouped into 3 according to their BMI as group 1 (BMI
between 30-34.99 kg/m  2  ), group 2 (BMI between 35-39.99 kg/m  2  ), and group 3
(BMI ≥ 40 kg/m  2  ).The macular and peripapillary thicknesses were measured using
an SD-OCT device. The foveal avascular zone (FAZ), the vessel density (VD) of the
superficial capillary plexus and deep capillary plexus of the macula, and the VD of the
retinal peripapillary capillary plexus (RPCP) for the optic disc were quantified by OCT-
A.
Results:  Totally 110 patients, 27 control cases,and 83 obese patients were included in
the study. There was not any significant difference between four groups regarding the
gender (p= 0.192). HbA1C, fasting insulin,HOMA-IR,CRP,AI levels were significantly
higher in obese patients compared with the control cases. Superficial (p= 0.003) and
deep (p= 0.001) VD’s of retina significantly decreased and FAZ significantly increased
(p= 0.032) in obese patients.  In correlation analysis performed between the clinical
features and OCT-A findings, the superficial and deep vessel densities inversely
correlated with age, BMI, Hb A1C, and AI.
Conclusion:  Retinal superficial and deep vessel densities are decreased in obese
patients and there was an inverse relationship between the retinal vessel densities and
age, BMI, Hb A1C, and AI.
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Purpose: This study aimed to evaluate the ocular alterations especially on retinal 
microvasculature of obese patients and to determine the association of these alterations with 
clinical features.  
Material and Methods:Height, body weight, blood lipid and glucose levels were recorded in all 
patients. BMI was calculated.In all participants, biochemical examinations were performed 
including cholesterol levels, fasting blood glucose, fasting insulin,CRP,Hb A1C levels.The 
atherogenic index of plasma was calculated as a logarithm of the ratio of the molar concentration 
(mmol/l) of TG to HDL-C (log [TG/HDL-C]).Patients with a BMI ≤ 25 kg/m2 were included in 
the control group. Obese patients were sub-grouped into 3 according to their BMI as group 1 
(BMI between 30-34.99 kg/m2), group 2 (BMI between 35-39.99 kg/m2), and group 3 (BMI ≥ 40 
kg/m2).The macular and peripapillary thicknesses were measured using an SD-OCT device. The 
foveal avascular zone (FAZ), the vessel density (VD) of the superficial capillary plexus and deep 
capillary plexus of the macula, and the VD of the retinal peripapillary capillary plexus (RPCP) 
for the optic disc were quantified by OCT-A.  
Results: Totally 110 patients, 27 control cases,and 83 obese patients were included in the study. 
There was not any significant difference between four groups regarding the gender (p= 0.192). 
HbA1C, fasting insulin,HOMA-IR,CRP,AI levels were significantly higher in obese patients 
compared with the control cases. Superficial (p= 0.003) and deep (p= 0.001) VD’s of retina 
significantly decreased and FAZ significantly increased (p= 0.032) in obese patients.  In 
correlation analysis performed between the clinical features and OCT-A findings, the superficial 
and deep vessel densities inversely correlated with age, BMI, Hb A1C, and AI.  
Conclusion: Retinal superficial and deep vessel densities are decreased in obese patients and 
there was an inverse relationship between the retinal vessel densities and age, BMI, Hb A1C, and 
AI.   




Obesity is an important public health concern worldwide, which is associated with 
increased risk for cardiovascular morbidity and mortality (1). Obesity, diabetes, dyslipidemia, 
insulin resistance, smoking and, hypertension are well-known risk factors that affect the vascular 
endothelium and endothelial response to the oxidative stress; resulting in microvascular 
remodeling (2-4). Nowadays, the atherogenic index of plasma is regarded as a novel predictive 
biomarker for cardiovascular diseases (5).  
 
Microvascular dysfunction is considered a crucial pathway in the development and 
progression of cardio-metabolic diseases. Inflammatory processes, oxidative stress, and 
endothelial dysfunction are the main mechanisms of microvascular dysfunction (6). Metabolic 
diseases are also known to have severe effects on the structure of the retinal circulation, mostly 
associated with endothelial dysfunction and inflammation (7). However, the data regarding the 
effects of obesity on ocular functions and retinal microvasculature is limited. Nowadays, retinal 
microvasculature is an easy-to-reach network structure where we can get the easiest and fastest 
information about the microvascular network all over the body by non-invasive methods (8). 
Retinal vessel diameters were shown to have a predictive role for long-term adult cardiovascular 
outcomes and atherosclerotic cardiovascular diseases (9). In daily ophthalmology practice, 
optical coherence tomography (OCT) is a widely used, non-invasive imaging method that offers 
high-resolution cross sectional scanning of ocular tissues. Moreover, with the development of 
spectral domain OCT (SD-OCT), the sensitivity and speed of OCT  systems are increased, 
enabling to visualize blood vessels through repeated scans. OCT angiography (OCT-A), provides 
detailed data on the microvascular structure of the retina and the choroid. 
  
 
This study aimed to evaluate the ocular alterations especially on retinal microvasculature 
of obese patients and to determine the association of these alterations with atherogenic index and 
body mass index.  
 
 
MATERIAL and METHOD 
This  retrospective study was performed in the ophthalmology department of Erzincan 
Binali Yıldırım University, Faculty of Medicine, Mengucek Gazi Training and Research Hospital  
between September 2019 and March 2020. The study was approved by the local ethics committee 
and performed in concordance with the principles of the 2008 Declaration of Helsinki. Informed 
consent was obtained from the participants.  
Study population 
Patients between the ages of 18 and 60 years, who were followed in our obesity center and 
agreed to participate in the study were included. The other inclusion criteria were as follows: 
refractive error ≤ ± 1 D or axial length between 22 and 24 mm, visual acuity ≥ 20/20, intraocular 
pressure ≤ 21 mmHg. Patients younger than 18 and older than 60 years of age, patients under 
treatment for diabetes mellitus, hyperlipidemia, or hypertension or any suspicious findings related 
to these diseases, patients diagnosed with any other systemic diseases such as sleep apnea 
syndrome, psychiatric disorders, cardiovascular diseases, kidney or renal failure, acute or chronic 
infection, anemia, thyroid pathologies that could affect the measurements were excluded from the 
study. Participants with a history of alcohol or drug use and smoking participants were excluded 
from the study. Extensive biochemical evaluation was  performed by taking fasting venous blood 
samples of all participants. Patients with any pathology in their values were excluded from the 
study. Patients having any ocular diseases (such as ectatic corneal diseases, chorioretinal 
diseases, cataract, glaucoma etc.) or ocular surgery were also excluded from the study. All 
patients were evaluated in endocrinology outpatient clinics, and patients with diabetes mellitus 
were not included in the study.  
 
Height, body weight, and blood lipid and glucose levels were recorded in all patients. 
Body mass index (BMI) was calculated using the following formula: BMI = body weight 
(kg)/height2 (m2).  
 
In all participants, for biochemical examinations, after 8h of fasting, 5 mL of venous 
blood was obtained from the cubital vein the following morning. Levels of total cholesterol (TC), 
low-density lipoprotein-cholesterol (LDL-C), high-density lipoprotein-cholesterol (HDL-C), 
triglyceride (TG), fasting blood glucose (FBG), fasting insulin, and hemoglobin A1c (HbA1c) 
levels were determined. The Homeostasis Model Assessment of IR (HOMA-IR) was calculated 
for the assessment of insulin resistance (11). For the evaluation of subclinical inflammation, C-
reactive protein level was studied. The atherogenic index of plasma (AI) was calculated as a 
logarithm of the ratio of the molar concentration (mmol/l) of TG to HDL-C (log [TG/HDL-C]) 
(12).  
 
Patients with a BMI ≤ 25 kg/m2 were included in the control group. All obese participants 
had a history of at least 5 years of obesity. Obese patients were sub-grouped into 3 according to 
their BMI as group 1 (BMI between 30-34.99 kg/m2),  group 2 (BMI between 35-39.99 kg/m2), 
and group 3 (BMI ≥ 40 kg/m2). Overweight patients having a BMI between 25.01 and 29.99 were 
not included in the study.  
 
Detailed ocular examinations were performed in all patients. All participants underwent 
detailed ophthalmologic examinations.  In this context, refraction measurement (Tonoref III, 
Nidec Co. Ltd, Aichi, Japan), best corrected visual acuity, slit lamp biomicroscopy, indirect 
ophthalmoscopy, non-contact biometry (AL-SCAN, Nidek Co. Ltd, Aichi, Japan), intraocular 
pressure (IOP) (Tonoref III, Nidec Co. Ltd, Aichi, Japan) measurement were carried out.   Retinal 
nerve fiber layer thickness (RNFLT), central macular thickness (CMT), and ganglion cell layer 
thickness (GCLT) were measured by SD-OCT , FAZ and VD measurements examined by OCT-
A (RS-3000 Advance AngioScan (Nidek Co. Ltd, Gamagori, Japan) ). Only the right eyes of the 
participants were examined.  
Scan Protocol 
The macular and peripapillary thicknesses were measured using an SD-OCT device 
(Nidek Co. Ltd., Aichi, Japan). The foveal avascular zone (FAZ), the vessel density (VD) of the 
superficial capillary plexus (SCP) and deep capillary plexus (DCP) of the macula, and the VD of 
the retinal peripapillary capillary plexus (RPCP) for the optic disc were quantified by OCT-A 
(RS-3000 Advance, Nidek Co. Ltd., Gamagori, Japan). The Nidek RS-3000 Advance OCT 
system and updated AngioScan software were used to evaluate SD-OCT and OCT-A images. The 
fovea is focused on using an OCT-A prototype internal fixation lamp, and 3x3 mm macula cubes, 
each consisting of 256 B-scans are generated. For RPCP, the scans included a 2.4 × 4 mm disc 
map centered on the optic nerve head. The macular and peripapillary vascular density as well as 
FAZ can be automatically calculated with this device.  
The SD-OCT and OCT-A measurements were performed by an experienced 
ophthalmologist after pupil dilation with 1% tropicamid eye drop (Tropamid, Bilim Ilac Ltd, 
Istanbul, Turkey). In cases where the signal strength index quality was <7/10, scanning was 
repeated. The FAZ and VD measurements in the superficial capillary plexus (Figure 1) and deep 
capillary plexus were measured. The automated segmentation determines the en face slab for the 
superficial retinal layer and deep retinal layer to extend from the internal limiting membrane to 
13 μm below of the inner nuclear layer,  and 8 μm below of the inner nuclear layer to 13 μm 
below of the outer nuclear layer respectively. VD was calculated as the percentage area occupied 
by flowing blood vessels in the selecting region. The VD of the retinal peripapillary capillary 
plexus (RPCP) for the S/I and TSNIT sectors can be observed from the OCT-A scans of the 
peripapillary area (Figure 2).The average retinal nerve fiber layer thickness (RNFLT) and central 
macular thickness (CMT) were also measured through SD-OCT analysis.  
Statistical Analyses 
Statistical analyses were performed with the SPSS version 21.0 (SPSS Inc, Chicago 
Illinois) statistical program. The parametric variables were expressed with mean ± standard 
deviation, while categorical variables were expressed with percentage (%). In the comparison of 
parametric data between 2 independent groups, an independent sample t-test was performed. For 
non-normally distributed data, the analysis was performed with the Mann-Whitney U test.  In 
more than two group comparisons; One-Way Anova and Bonferroni post-hoc analysis were used 
for parametric data. Pearson correlation analysis was performed to determine the association of 




Totally 110 patients, 27 control cases (24 female, 3 male), and 83 obese patients (62 
female, 21 male), were included in the study. There was not any significant difference between 
the control cases and obese patients regarding gender (p= 0.180).  
 
The participants were grouped into four according to their BMI as follows;  
 Control group: BMI between 20-25 kg/m2: 27 patients (24 female, 3 male) 
Group 1: BMI between 30-35 kg/m2: 27 patients (21 female, 6 male) 
Group 2- BMI between 35.01-40 kg/m2: 27 patients (22 female, 5 male) 
Group 3- BMI > 40 kg/m2: 29 patients (19 female, 10 male) 




Demographic features and laboratory data of the study participants are summarized in 
Table 1. Hemoglobin A1C, fasting insulin, HOMA-IR, CRP, TG, HDL-C, and AI levels were 
significantly different between groups (p=0.008, p=0.001, p=0.001, p=0.001, p=0.015, p=0.001, 
p=0.008, respectively).  
 
 
Ocular findings of study participants are summarized in Table 2. There was not any 
significant difference between groups regarding the RNFLT, GCLT, CMT, or RPCP values. 
However, superficial and deep global vessel densities were significantly decreased in obese 
patients (p=0.003, p=0.001, respectively). FAZ measurements were significantly higher in obese 
patients (p=0.032). 
In correlation analysis performed between the clinical features and OCT-A findings, there 
VD superficial and deep vessel densities inversely correlated with age, BMI, HbA1c, and AI; 




In this study, we investigated the ocular findings in obese patients and we did not 
determine any significant alteration in retinal nerve fiber layer thickness, ganglion cell layer 
thickness, central macular thickness, or radial peripapillary capillary plexus vessel density with 
obesity or with an increase in BMI. However, both superficial and deep vessel densities of retina 
decreased with obesity. To the best of our knowledge, this is the first study evaluating the 
relationship of retinal vascular alterations with metabolic parameters in obese patients and we 
determined that with an increase in age, BMI, Hb A1C and/or, atherogenic index, superficial and 
deep vessel densities of the retina was decreasing significantly.  
In recent years, the OCTA device has been widely used due to its short imaging time and 
no side effects. Nidek has recently updated the AngioScan software, but the normative data for 
the new version of the device are limited in the literature (10). Although it is not possible to 
standardize the measured values since different gravity techniques are used in different OCTA 
devices, the benefit of the evaluated data in the ophthalmology clinics is obvious in terms of 
evaluating the retinal microvascular structure. 
Obesity is a well-known risk factor for microvascular alterations and remodeling. In this 
study, we investigated the ocular changes in retinal microvasculature in obese patients and 
associations of these alterations with metabolic parameters. We determined an inverse correlation 
between BMI and superficial and deep retinal vessel densities. Similar to our results, in a meta-
analysis, Köchli et al reported that a higher BMI was associated with narrower retinal arteriolar 
and wider venular diameters in children (13). In another meta-analysis Boilot et al (14) also 
reported that higher BMI was associated with narrower retinal arteriolar and wider venular 
calibers. We also determined a significant decrease in both superficial and deep vessel densities 
of the retina with an increase in BMI.  
With an increase in BMI, there was a significant increase in AI, and a significant decrease 
in superficial and deep vessel densities of the retina. Moreover, there was an inverse significant 
correlation between AI and vessel densities. To the best of our knowledge, this is the first study 
in the literature evaluating the association of AI with OCT-A findings. On the same way with our 
findings, Krasnicki et al (15) reported that flow disturbances within the ocular blood vessels of 
patients with type 2 diabetes were associated with atherogenic changes of coronary arteries. In a 
population-based cohort study, Shankar et al (16) reported that wider retinal venules were 
positively associated with the risk of developing obesity, suggesting a role for microvascular 
dysfunction in early periods of obesity. However, in a recent population-based cohort study, it 
was reported that; age and FPG were inversely associated with retinal microvascular functions, 
but 24-h systolic blood pressure, waist circumference, and total-to-HDL cholesterol ratio were 
not associated with these microvascular functions (17). Xiao et al (18) also reported that 
adolescents with dyslipidemia had significantly narrower retinal arteriolar diameters compared 
with normolipidemic counterparts, but they did not determine any significant relationship 
between lipid subclass levels and central retinal venular equivalent. We also determined an 
inverse relationship between age and the retinal vasculature. Nowadays, the atherogenic index of 
plasma is regarded as a novel predictive biomarker for cardiovascular diseases and we believe 
that it may also be playing an important role in vascular alterations of the retina (5, 19).  
Hb A1C has been defined to have a prognostic value for cardiovascular diseases in non-
diabetic patients (20, 21). In this study on non-diabetic patients, we also determined that there 
was a significant increase in Hb A1C levels with an increase in BMI in obese patients and there 
was an inverse correlation between HbA1c and superficial and deep vessel densities of the retina.  
In this study, we did not determine any association between serum CRP levels and OCT-
A findings. In previous literature, the data regarding the association of CRP levels with 
cardiovascular risk assessment is conflicting (22, 23). Though CRP is a sign of inflammation, it 
may be affected by many other factors and in this study, though in obese patients, the mean CRP 
levels were significantly higher than that of the control cases, the CRP levels were still low. The 
low differences in mean CRP levels between groups may be associated with the exclusion of all 
patients with any chronic diseases from the study. This low difference may be the reason, we did 
not determine any association between the CRP levels and OCT-A findings.   
There are some limitations of this study that should be mentioned. First is that, though we 
excluded all patients with any systemic diseases including primary hypertension, we did not note 
systolic and diastolic blood pressure values, which are parameters that could affect OCTA 
measurements. Secondly, while there was not any significant difference between groups 
regarding gender, evaluating males and females in different groups may be more appropriate, 
since metabolic factors may have different effects on both genders. The other limitation is 
overweight patients having a BMI between 25.01 and 29.99 were not included in the study 
because there was no follow-up patient with these BMI values in the obesity center.  
In conclusion, retinal superficial and deep vessel densities are decreased in obese patients 
and there was an inverse relationship between the retinal vessel densities and age, BMI, Hb A1C, 
and AI. Recently retinal vessel alterations are shown to be sensitive microvascular biomarkers for 
cardiovascular risk stratification. Due to the association of these retinal vasculature alterations, 
which can be investigated with non-invasive methods, we suggest that retinal vasculature should 
be evaluated in patients with metabolic risk factors, such as elevated AI, BMI and older age, to 
treat these vascular alterations as early as possible and predict the cardiovascular morbidity and 
mortality at early stages. It is obvious that the cross-sectional data can provide limited 
information in this study where the atherogenic index and BMI effects were investigated on the 
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Legends: 
Table 1. Demographic features and laboratory data of the study participants. 
Table 2. Ocular findings of the study participants. 
Table 3. Correlation analysis performed between the clinical features and OCT-A findings. 
Figure 1. OCTA image of a 29-year-old woman with BMI = 32 kg / m2 . The FAZ metrics were 
autodetected by the AngioScan software. The image also displays VD measurements in the SCP 
layer. 
Figure 2. Peripapillary vessel density colored map and VD distribution at the level of the RPCP 
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Table 1. Demographic features and laboratory data of the study participants. 
 




Group 1  
(BMI between 30-
35 kg/m2) (n:27) 




(BMI > 40 
kg/m2) (n:29) 
P-value 
Age (years) 42.03±10.44 43.12±10.87 39.55±9.97 39.41±10.32 0.122 
FBG (mg/dL) 89.18±15.28 89.22±11.87 93.77±10.22 95.86±7.10 0.112 
HbA1c (%) 5.28±0.25 5.40±0.30 5.51±0.24b 5.54±0.27c 0.008 
Fasting insulin 
(µIU/mL) 
6.48±5.26 12.26±6.17a 12.55±6.82b 14.76±10.61c 0.001 
HOMA-IR 1.41±1.12 2.75±1.53a 2.76±1.59b 3.63±2.93c 0.001 




178.15±36.79 193.80±46.97 186.34±39.69 179.23±41.60 0.115 
TG (mg/dL) 104.18±55.69 125.31±40.28a 129.65±48.52b 134.09±53.5c 0.015 
HDL-C 
(mg/dL) 
51.20±5.61 43.35±11.17a 43.15±9.59b 42.78±8.72c 0.001 
LDL-C 
(mg/dL) 
106.11±29.40 118.74±44.26 119.25±33.15 119.46±37.00 0.082 
AI -0.08±0.015 0.022± 0.025a 0.066±0.019b 0.071±0.025c 0.008 
FBG: Fasting blood glucose, HbA1c: hemoglobin A1C, CRP: C-reactive protein, HDL-C: high-density 
lipoprotein-cholesterol, LDL-C: low-density lipoprotein-cholesterol, AI: atherogenic index, a: statistically 
significantly different when group 1 is compared with the control group; b: statistically significantly different when 
group 2 is compared with the control group; c: statistically significantly different when group 3 is compared with 
the control group. The significant P values expressed with bold style. 
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Table 2. Ocular findings of the study participants 












Group 3 (BMI 





115.29±5.09 111.25±9.76 108.22±14.24 110.03±9.23 0.73 
GCLT, sup (μm) 101.03±3.76 100.11±7.60 97.85±8.78 99.27±7.70 0.532 
GCLT, inf (μm) 103.96±5.77 101.55±7.31 100.66±9.06 103.55±8.52 0.307 
CMT (μm) 260.40±14.00 260.63±20.50 259.18±24.56 265.10±21.26 0.698 
RPCP VD (%) 54.01±3.23 54.37±4.02 53.44±3.82 53.51±2.97 0.834 
FAZ (mm2) 0.32±0.083 0.40±0.13a 0.41±0.15b 0.41±0.21c 0.032 
SCP VD (%) 43.77±1.80 40.48±4.40 39.37±5.50b 37.62±5.88c 0.003 
DCP VD  (%) 38.03±3.56 32.33±7.98a 32.69±7.48b 29.74±7.96c 0.001 
RNFLT: retinal nerve fiber layer thickness, GC: ganglion cell layer thickness, sup: superior, inf: inferior, CMT: 
central macular thickness, RPCP: radial peripapillary capillary plexus, FAZ: foveal avascular zone, VD: vessel 
density, SCP: Superficial capillary plexus, DCP: Deep capillary plexus. a: statistically significantly different 
when group 1 is compared with the control group; b: statistically significantly different when group 2 is 
compared with the control group; c: statistically significantly different when group 3 is compared with the control 
group. The significant P values expressed with bold style. 
Table Click here to access/download;Table;Table 2.docx
Table 3. Correlation analysis performed between the clinical features and OCT-A 
findings. 
 FAZ VD superficial VD deep 
 r p r p r p 
Age (years) 0.086 0.373 -0.190 0.045 -0.218 0.022 
BMI 0.275 0.004 -0.354 0.001 -0.349 0.001 
HbA1c 0.022 0.818 -0.190 0.046 -0.189 0.048 
HOMA-IR 0.022 0.817 -0.044 0.649 -0.027 0.783 
CRP 0.111 0.249 -0.129 0.180 -0.145 0.131 
AI 0.113 0.157 -0.254 0.007 -0.213 0.026 
BMI: Body mass index, HbA1c: hemoglobin A1C, CRP: C-reactive protein, AI: atherogenic index. The significant 
P values expressed with bold style. 
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been associated with various ocular pathologies. In 
this study, we investigated optical coherence 
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previous studies have investigated the potential 
relationship. Thus this is the first study in this field. 
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